Table 3.4 Reported cases of laboratory-confirmed, chronic hepatitis B virus (HBV) infection, by sex, race/ethnicity, age group, place of birth and case criteria — Emerging Infections Program (EIP) Hepatitis Surveillance Demonstration Sites, 2011
|
Category
|
CO No. (%) |
CT No. (%) |
MN No. (%) |
NM No. (%) |
NY State No. (%) |
NY City No. (%) |
OR No. (%) |
San Francisco No. (%) |
Total No. (%) |
|---|---|---|---|---|---|---|---|---|---|
|
Sex
|
|||||||||
|
Female
|
67 (43.0) |
174 (49.4) |
314 (44.4) |
24 (38.7) |
804 (41.9) |
3174 (45.6) |
195 (45.9) |
444 (48.3) |
5196 (45.2) |
|
Male
|
89 (57.1) |
178 (50.6) |
391 (55.2) |
38 (61.3) |
1117 (58.2) |
3779 (54.3) |
229 (53.9) |
475 (51.6) |
6296 (54.7) |
|
Missing
|
0 (0.0) |
0 (0.0) |
3 (0.4) |
0 (0.0) |
0 (0.0) |
3 (0.0) |
1 (0.2) |
1 (0.1) |
8 (0.1) |
|
Race/Ethnicity*
|
|||||||||
|
AI / AN
|
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
4 (0.2) |
1 (0.0) |
8 (1.9) |
5 (0.5) |
18 (0.2) |
|
API
|
55 (35.3) |
141 (40.1) |
246 (34.8) |
34 (54.8) |
577 (30.0) |
1218 (17.5) |
246 (57.9) |
514 (55.9) |
3031 (26.4) |
|
Black
|
25 (16.0) |
58 (16.5) |
187 (26.4) |
4 (6.5) |
310 (16.1) |
448 (6.4) |
24 (5.7) |
19 (2.1) |
677 (5.9) |
|
White
|
31 (19.9) |
70 (19.9) |
39 (5.5) |
10 (16.1) |
278 (14.5) |
125 (1.8) |
101 (23.8) |
23 (2.5) |
677 (5.9) |
|
Hispanic
|
7 (4.5) |
36 (10.2) |
5 (0.7) |
7 (11.3) |
87 (4.5) |
109 (1.6) |
9 (2.1) |
7 (0.8) |
267 (2.3) |
|
Other
|
4 (2.6) |
5 (1.4) |
12 (1.7) |
0 (0.0) |
31 (1.6) |
29 (0.4) |
0 (0.0) |
6 (0.7) |
87 (0.8) |
|
Unknown / Missing
|
34 (21.8) |
42 (11.9) |
219 (30.9) |
7 (11.3) |
634 (33.0) |
5026 (72.3) |
37 (8.7) |
346 (37.6) |
6345 (55.1) |
|
Age group (yrs)
|
|||||||||
|
0-14
|
6 (3.9) |
3 (0.9) |
35 (4.9) |
2 (3.2) |
27 (1.4) |
55 (0.8) |
19 (4.5) |
4 (0.4) |
151 (1.3) |
|
15-24
|
17 (10.9) |
20 (5.7) |
114 (16.1) |
6 (9.7) |
123 (6.4) |
670 (9.6) |
20 (4.7) |
28 (3.0) |
998 (8.7) |
|
25-39
|
67 (43.0) |
154 (33.8) |
291 (41.1) |
15 (24.2) |
553 (28.8) |
2859 (41.1) |
161 (37.9) |
238 (25.9) |
4338 (37.7) |
|
40-54
|
44 (28.2) |
103 (29.3) |
169 (23.9) |
22 (35.5) |
735 (38.3) |
2206 (31.7) |
143 (33.7) |
328 (35.7) |
3750 (32.6) |
|
55+
|
22 (14.1) |
72 (20.5) |
99 (14.0) |
17 (27.4) |
483 (25.1) |
1166 (16.8) |
82 (19.3) |
322 (35.0) |
2263 (19.7) |
|
Missing
|
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
Place of Birth
|
|||||||||
|
United States
|
14 (9.0) |
40 (11.4) |
25 (3.5) |
U (U) |
125 (6.5) |
10 (0.1) |
81 (19.1) |
12 (1.3) |
307 (2.7) |
|
Outside US
|
77 (49.4) |
147 (41.8) |
218 (30.8) |
U (U) |
1796 (93.5) |
176 (2.5) |
198 (46.6) |
104 (11.3) |
2981 (25.9) |
|
Missing/
Unknown |
65 (41.7) |
147 (41.8) |
218 (30.8) |
U (U) |
0 (0.0) |
6770 (97.3) |
146 (34.4) |
804 (87.4) |
8150 (70.9) |
|
Positive Laboratory Tests†
|
|||||||||
|
HBV surface antigen
|
148 (94.9) |
350 (99.4) |
686 (96.9) |
U (U) |
1865 (97.1) |
6642 (95.5) |
381 (89.7) |
830 (90.2) |
10902 (94.8) |
|
HBV “e” antigen
|
25 (16.0) |
51 (14.5) |
184 (26.0) |
U (U) |
365 (19.0) |
1379 (19.8) |
83 (19.5) |
117 (12.7) |
2204 (19.2) |
|
HBV-DNA
|
64 (41.0) |
131 (37.2) |
464 (65.5) |
U (U) |
1294 (67.4) |
5487 (78.9) |
163 (38.4) |
629 (68.4) |
8232 (71.6) |
|
Total new
reported cases |
156 | 352 | 708 | 62 | 1,921 | 6,956 | 425 | 920 | 11,500 |
|
Estimated 2010
population |
5,116,796 | 3,580,709 | 5,344,861 | 2,082,224 | 11,220,287 | 8,175,133 | 3,871,826 | 812,826 | 40,274,472 |
|
Rate per 100,000 population
|
3.0 | 9.8 | 13.2 | 3.0 | 17.1 | 84.4 | 11.0 | 113.2 | 28.6 |
*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting
Page last reviewed: August 19, 2013